COMBINATION OF DEPIGMENTING AGENTS IN VITRO 375 (4) K. H. Son and M. Y. Heo, The evaluation of depigmenting effi cacy in the skin for the development of new whitening agents in Korea, Int. J. Cosmet. Sci., 35, 9–18 (2013). (5) A. M. Kligman and I. Willis, A new formula for depigmenting human skin, Arch. Dermatol., 111, 40– 48 (1975). (6) I. Majid, Mometasome-based triple combination therapy in melasma: Is it really safe?, Indian J. Derma- tol., 55, 359–362 (2012). (7) D. McGregor, Hydroquinone: An evaluation of the human risks from its carcinogenic and mutagenic properties, Crit. Rev. Toxicol., 37, 887–914 (2007). (8) T. Chang, An updated review of tyrosinase inhibitors, Int. J. Mol. Sci., 10, 2440–2475 (2009). (9) K. Maeda and M. Fukuda, Arbutin: Mechanism of its depigmenting action in human melanocyte cul- ture, J. Pharmacol. Exp. Ther., 276, 765–769 (1996). (10) S. Parvez, M. Kang, H. Chung, C. Cho, M. Hong, M. Shin, and H. Bae, Survey and mechanism of skin depigmenting and lightening agents, Phytother. Res., 20, 921–934 (2006). (11) Y. Tokiwa, K. Kitagawa, and T. Raku, Enzymatic synthesis of arbutin undecylenic acid ester and its inhibitory effect on mushroom tyrosinase, Biotechnol. Lett., 29, 481–486 (2007). (12) V. Kahn, Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mush- room tyrosinase, Pigment Cell Res., 8, 234–240 (1995). (13) A. F. Lajis, M. Hamid, and A. Ariff, Depigmenting effect of kojic acid esters in hyperpigmented B16F1 melanoma cells, J. Biomed. Biotechnol., 1–9 (2012). (14) G. A. Burdock, M. G. Soni, and I. G. Carabin, Evaluation of health aspects of kojic acid in food, Regul. Toxicol. Pharmacol., 33, 80–101 (2001). (15) N. Smit, J. Vicanova, and S. Pavel, The hunt for natural skin whitening agents, Int. J. Mol. Sci., 10, 5326–5349 (2009). (16) L. Lemic-Stojcevic, A. H. Nias, A. S. Breathnach, Effect of azelaic acid on melanoma cells in culture, Exp. Dermatol., 4, 79–81 (1995). (17) K. Tsuji-Naito, T. Hatani, T. Okada, and T. Tehara, Evidence for covalent lipoyl adduction with dopa- quinone following tyrosinase-catalyzed oxidation, Biochem. Biophys. Res. Commun., 343, 15–20 (2006). (18) C. B. Lin, L. Babiarz, F. Liebel, E. R. Price, M. Kizoulis, G. J. Gendimenico, D. E. Fisher, and M. Seiberg, Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation, J. Invest. Dermatol., 119, 1330–1340 (2002). (19) K. Park, S. Huh, H. Cho, and D. Kim, Biology of melanogenesis and the search for hypopigmenting agents. Dermatologica Sinica., 28, 53–58 (2010). (20) T. Unno, F. Ito, and Y. M. Sagesaka, Alpha-lipoic acid inhibits melanogenesis in three-dimensional hu- man skin model, Food Sci. Technol. Res., 15, 537–540 (2009). (21) Z. Qiao, Y. Koizumi, M. Zhang, M. Natsui, M. J. Flores, L. Gao, K. Yusa, S. Koyota, and T. Sugiyama, Anti-melanogenesis effect of Glechoma heredacea L. extract on B16 murine melanoma cells, Biosci. Biotech- nol. Biochem., 76, 1877–1883 (2012). (22) M. B Mapunya, R. V. Nikolova, and N. Lall, Melanogenesis and antityrosinase activity of selected South African plants, Evid. Based Complement Alternat. Med., 1, 1–6 (2012). (23) T. C. Chou, Theoretical basis, experimental design, and computerized simulation of synergism and an- tagonism in drug combination studies, Pharmacol. Rev., 58, 621–681 (2006). (24) Y. M. Ha, S. W. Chung, S. Song, H. Lee, H. Suh, and H. Y. Chung, 4-(6-Hydroxy-2-naphthyl)-1, 3-bezendiol: A potent, new tyrosinase inhibitor. Biol. Pharm. Bull., 30, 1711–1715 (2007). (25) N. Seyfi zadeh, S. Mahjoub, and E. Zabihi, Cytoprotective effects of arbutin against tert-butyl hydroperoxide- induced toxicity in Hep-G2 cell line, World Appl. Sci. J., 19, 163–167 (2012). (26) J. Takebayashi, R. Ishii, J. Chen, T. Matsumoto, Y. Ishimi, A. Tai, Reassessment of antioxidant activity of arbutin: Multifaceted evaluation using fi ve antioxidant assay systems. Free Radic. Res., 44, 473–478 (2010). (27) W. Sun, M. Wendt, G. Klebe, and K. Röhm, On the interpretation of tyrosinase inhibition kinetics, J Enzyme Inhib. Med. Chem., 29, 92–99 (2014). (28) S. S. Tai, C. G. Lin, M. H. Wu, T. S. Chang, Evaluation of depigmenting activity by 8-hydroxydaidzein in mouse B16 melanoma cells and human volunteers, Int. J. Mol. Sci., 10, 4257–4266 (2009). (29) S. Lee, S. Cho, Y. Kwon, H. Kwon, and W. Shin, Inhibitory effects of ethanol extracts from nuruk on oxidative stress, melanogenesis, and photo-aging, Mycobiology, 40, 117–123 (2012). (30) F. Solano, S. Briganti, M. Picardo, and G. Ghanem, Hypopigmenting agents: An updated review on biological, chemical and clinical aspects, Pigment Cell Res., 19, 550–571 (2006).